BML Capital Management as of June 30, 2024
Portfolio Holdings for BML Capital Management
BML Capital Management holds 28 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ishares Tr 0-3 Mnth Treasry (SGOV) | 19.4 | $27M | 270k | 100.71 | |
Atea Pharmaceuticals (AVIR) | 15.1 | $21M | 6.4M | 3.31 | |
Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 13.1 | $18M | 200k | 91.78 | |
Aclaris Therapeutics (ACRS) | 10.2 | $14M | 13M | 1.10 | |
Adverum Biotechnologies Com New (ADVM) | 9.6 | $14M | 2.0M | 6.86 | |
Tectonic Therapeutic (TECX) | 5.5 | $7.7M | 466k | 16.47 | |
Reneo Pharmaceuticals (RPHM) | 2.9 | $4.0M | 2.7M | 1.51 | |
Instil Bio Com New (TIL) | 2.9 | $4.0M | 391k | 10.29 | |
Wingstop Put Option (WING) | 2.6 | $3.6M | 714.00 | 5018.28 | |
Oramed Pharmaceuticals Com New (ORMP) | 2.5 | $3.5M | 1.3M | 2.57 | |
Connect Biopharma Hldgs Ads (CNTB) | 2.2 | $3.1M | 2.0M | 1.52 | |
Athira Pharma (ATHA) | 1.7 | $2.4M | 900k | 2.65 | |
Vanda Pharmaceuticals (VNDA) | 1.6 | $2.3M | 398k | 5.65 | |
Pmv Pharmaceuticals (PMVP) | 1.5 | $2.1M | 1.3M | 1.62 | |
Astrotech Corp (ASTC) | 1.4 | $2.0M | 220k | 8.90 | |
Milestone Pharmaceuticals (MIST) | 1.0 | $1.5M | 1.1M | 1.32 | |
Design Therapeutics (DSGN) | 1.0 | $1.4M | 422k | 3.35 | |
Verrica Pharmaceuticals (VRCA) | 0.9 | $1.3M | 180k | 7.29 | |
Lenz Therapeutics (LENZ) | 0.8 | $1.1M | 64k | 17.29 | |
Lisata Therapeutics (LSTA) | 0.7 | $988k | 285k | 3.47 | |
Ikena Oncology (IKNA) | 0.7 | $965k | 585k | 1.65 | |
Forte Biosciences (FBRX) | 0.7 | $946k | 1.8M | 0.54 | |
Calcimedica Com New (CALC) | 0.5 | $635k | 160k | 3.96 | |
Vistagen Therapeutics Ord (VTGN) | 0.4 | $522k | 150k | 3.48 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.4 | $510k | 625k | 0.81 | |
Nextcure (NXTC) | 0.3 | $440k | 277k | 1.59 | |
Allovir (ALVR) | 0.3 | $436k | 603k | 0.72 | |
Talis Biomedical Corp Com New (TLIS) | 0.3 | $370k | 43k | 8.66 |